Bengaluru-based Eyestem raises $6.4 M in Series A round
Post this funding, the company will enhance its cell therapy platform
Stay updated with breaking news from Be Limited. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Post this funding, the company will enhance its cell therapy platform
Existing investors Endiya Partners and Kotak Private Equity also participated in this round, valuing Eyestem at $46.4 million (Rs 371 crore) post-money, it said in a statement on Monday.
As India is cementing Hyderabad position as the Vaccine Capital of the World, Biological E has announced its expansion plans for vaccine manufacturing with
The move comes a few weeks after receiving the EUA for children between the ages of 5 and 12
The price of COVID-19 vaccine Corbevax has been reduced to Rs 250 a dose from its earlier Rs 840, said Biological E Limited (BE) on Monday.